We therefore compared the levels of AAT secretion by CD4+ and CD8+ T cells treated with 1,25(OH)2D3 in cohorts of healthy controls, patients with COPD, and PiZZ AAT deficient individuals (Figure 5B). This evidence concerns the gene CD4 and chronic obstructive pulmonary disease.